EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS193-00625 
Organism
Homo sapiens 
Tissue/cell
U87 
Coordinate
chr1:27424440-27425290 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Nr2f6(var.2)MA0728.1chr1:27424515-27424530TGAACTCCTGACCTC-6.22
Number of super-enhancer constituents: 9             
IDCoordinateTissue/cell
SE_08182chr1:27425069-27426923Brain_Inferior_Temporal_Lobe
SE_09350chr1:27423956-27427835CD14
SE_31553chr1:27424644-27427446Gastric
SE_37352chr1:27424732-27427270HSMMtube
SE_41510chr1:27424454-27427884Left_Ventricle
SE_42522chr1:27424544-27427894Lung
SE_50517chr1:27424763-27426976Sigmoid_Colon
SE_52500chr1:27425172-27427288Small_Intestine
SE_53642chr1:27424607-27427217Spleen
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr12742491227425287
Number: 1             
IDChromosomeStartEnd
GH01I027098chr12742456127428202
Enhancer Sequence
CATACATCAC CATGCCCAGC TAATTTTTGT ATTTTTAGTA GAGATGGGGT TTTGCCATGT 60
TGGCCAGGCT GGTCTTGAAC TCCTGACCTC AGGTGATCCG CCCAGCTTGG CCTCCCAAAG 120
TGCTGGGATT ACAGGCATGA GCCACCGCGC CCGGCCCAAT TTTATATATT TTAAATATTG 180
CACATGCAGC AAAGTTTTGA CTGTCTCATG AGGTCAGGTG TGCATTCTCC ATTCATGGCG 240
TTGTGTTGGG TTTTCTGATT AGGGAGGCTC AGTTTGTACA CACCTGAGCT TATCTCATGC 300
AGGGGTCACT GTCCCCACTT TACAGGTGAG AACTTGAGGG CTTCAGTGAC TTCCCACTGC 360
CCTTTTGGTC TTCCCACGGT TAAGAGCAAA ATCTTAACCA TGGAGCACGC GGCCCCATCC 420
TTGCCTCCCC TGTCACTCTG ACCCAGCCAC CCGGCCTTTT CTCAGGTCCC AGTGTTCGTG 480
GGCACAGCTC CCAGTTACAA TGTTTGGGAA CTTTCTGGGT CCTTTTCCAC CCGGAAGCCT 540
TGGCTCCTTC TTCAGTCCCC TCCTGGGATC TCACTCACTC GGGACTCAGG AGGGTCCTCC 600
TCGCCGTCCC TCCCTCCCCT CTGCCTCTTT TTCACCTCTT GCACAAACAC TGGGCACTGG 660
TTAGTGCCGC TCTCCCCCGC GGGGCAGGGC ACGTCCTGCT TAGCTCATTG TGGTATCTCA 720
GTGCCTGGCA TGTGGGAACA ACCACCCCAG CAGCTGACAG CCATGAAGTG TTTCTGTGCC 780
AGCCTTTGAA CTAAGTACTT CACGCCCTCA GGCCACCCTC CCTCCTAAAG ACCCTCGTCC 840
CCAGAAAGCA 850